Not immune from disparity: Two decades of racial minority participation in immunotherapy trials for breast and gynecologic cancers

Abstract

Objective: It is well established that cancer health disparities exist among minority women. While the causes are multifaceted, one theory focuses on lack of minority participation in clinical trials. Although prior studies have suggested that differences in tumor biology do exist in minority women, current enrollment protocols do not take this into consideration. Our objective is to evaluate minority participation in immunotherapy trials for gynecologic and breast cancers.